Harrisburg-based firm invests $1.5 million into Pennsylvania health care technologies

Ioannis Pashakis//January 28, 2021

Harrisburg-based venture capital investment firm The Life Sciences Greenhouse of Central Pennsylvania (LSGPA) invested $1.5 million last year into three Pennsylvania health care companies.

LSGPA was founded in 2002 and provides early state investment and business development services to businesses that it sees having a significant impact on the future of health care.

“LSGPA is proud of its reputation for identifying and investing in young companies with the potential to both advance human health and positively impact the commonwealth’s economy,” said Dr. Mel Billingsley, the firm’s president and CEO. “Among the lessons to be learned from the pandemic is the importance of ongoing investment in healthcare innovation.”

Last year, LSGPA invested $1 million in MacuLogix Inc. a medical device company based in Harrisburg. MacuLogix is working to eliminate blindness caused by age-related macular degeneration (AMD) through the education of eye care professionals as well as through AdaptDxPro, the firm’s eye tracking headset.

The funding helped support the launch of AdaptDxPro, according to LSGPA.

LSGPA also invested $500,000 in Micro Interventional Devices Inc., a Newtown, Bucks County-based medical technology developer boasting technology allowing surgeons and interventionalists to perform minimally invasive structural heart procedures.

Finally, LSGPA invested $50,000 into Philadelphia-based Respana Therapeutics, a company developing therapeutic monoclonal antibodies for the treatment of complications from respiratory illnesses like influenza and COVID-19.

Select Region or Brand

Upcoming Event